A daganatok és a daganatmegelozo állapotok molekuláris epidemiológiája

Translated title of the contribution: The molecular epidemiology of tumors

I. Ember, István Kiss, J. Sándor, Csaba Varga, Zoltán Gyöngyi, Katalin Németh, Katalin Fehér, Péter Lukács, Zsuzsanna Dombi

Research output: Contribution to journalArticle

Abstract

For many years the molecular biology has been one of the most promising fields of science and its several methods have been used in practice. These new methods of molecular biology made impression on epidemiology and developed a new disclipine, called molecular epidemiology. The molecular and predictive epidemiology play more and more important roles in the prevention of cancers. Early biomarkers could identify the high risk population to have the possibilities of primary preventive interventions. It uses both molecular biological methods and the elements of epidemiology. Its specificity is not high enough to establish the diagnosis but it can be used to follow the "minimal residual disease" and with markers of individual susceptibility, to assesss the risk of tumors. As to the practice there are many problems because of the limited therapeutic possibilities, but the molecular and predictive epidemiology becomes an important part of medicine in the future.

Original languageHungarian
Pages (from-to)507-514
Number of pages8
JournalOrvosi Hetilap
Volume145
Issue number10
Publication statusPublished - Mar 2004

Fingerprint

Molecular Epidemiology
Molecular Biology
Epidemiology
Neoplasms
Residual Neoplasm
Biomarkers
Medicine
Population
Therapeutics

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Ember, I., Kiss, I., Sándor, J., Varga, C., Gyöngyi, Z., Németh, K., ... Dombi, Z. (2004). A daganatok és a daganatmegelozo állapotok molekuláris epidemiológiája. Orvosi Hetilap, 145(10), 507-514.

A daganatok és a daganatmegelozo állapotok molekuláris epidemiológiája. / Ember, I.; Kiss, István; Sándor, J.; Varga, Csaba; Gyöngyi, Zoltán; Németh, Katalin; Fehér, Katalin; Lukács, Péter; Dombi, Zsuzsanna.

In: Orvosi Hetilap, Vol. 145, No. 10, 03.2004, p. 507-514.

Research output: Contribution to journalArticle

Ember, I, Kiss, I, Sándor, J, Varga, C, Gyöngyi, Z, Németh, K, Fehér, K, Lukács, P & Dombi, Z 2004, 'A daganatok és a daganatmegelozo állapotok molekuláris epidemiológiája', Orvosi Hetilap, vol. 145, no. 10, pp. 507-514.
Ember I, Kiss I, Sándor J, Varga C, Gyöngyi Z, Németh K et al. A daganatok és a daganatmegelozo állapotok molekuláris epidemiológiája. Orvosi Hetilap. 2004 Mar;145(10):507-514.
Ember, I. ; Kiss, István ; Sándor, J. ; Varga, Csaba ; Gyöngyi, Zoltán ; Németh, Katalin ; Fehér, Katalin ; Lukács, Péter ; Dombi, Zsuzsanna. / A daganatok és a daganatmegelozo állapotok molekuláris epidemiológiája. In: Orvosi Hetilap. 2004 ; Vol. 145, No. 10. pp. 507-514.
@article{793bc7f686454d5c9d23d0111ac0e1b8,
title = "A daganatok {\'e}s a daganatmegelozo {\'a}llapotok molekul{\'a}ris epidemiol{\'o}gi{\'a}ja",
abstract = "For many years the molecular biology has been one of the most promising fields of science and its several methods have been used in practice. These new methods of molecular biology made impression on epidemiology and developed a new disclipine, called molecular epidemiology. The molecular and predictive epidemiology play more and more important roles in the prevention of cancers. Early biomarkers could identify the high risk population to have the possibilities of primary preventive interventions. It uses both molecular biological methods and the elements of epidemiology. Its specificity is not high enough to establish the diagnosis but it can be used to follow the {"}minimal residual disease{"} and with markers of individual susceptibility, to assesss the risk of tumors. As to the practice there are many problems because of the limited therapeutic possibilities, but the molecular and predictive epidemiology becomes an important part of medicine in the future.",
keywords = "Biomarker, Molecular epidemiology, Prevention, Risk assessment",
author = "I. Ember and Istv{\'a}n Kiss and J. S{\'a}ndor and Csaba Varga and Zolt{\'a}n Gy{\"o}ngyi and Katalin N{\'e}meth and Katalin Feh{\'e}r and P{\'e}ter Luk{\'a}cs and Zsuzsanna Dombi",
year = "2004",
month = "3",
language = "Hungarian",
volume = "145",
pages = "507--514",
journal = "Orvosi Hetilap",
issn = "0030-6002",
publisher = "Akademiai Kiado",
number = "10",

}

TY - JOUR

T1 - A daganatok és a daganatmegelozo állapotok molekuláris epidemiológiája

AU - Ember, I.

AU - Kiss, István

AU - Sándor, J.

AU - Varga, Csaba

AU - Gyöngyi, Zoltán

AU - Németh, Katalin

AU - Fehér, Katalin

AU - Lukács, Péter

AU - Dombi, Zsuzsanna

PY - 2004/3

Y1 - 2004/3

N2 - For many years the molecular biology has been one of the most promising fields of science and its several methods have been used in practice. These new methods of molecular biology made impression on epidemiology and developed a new disclipine, called molecular epidemiology. The molecular and predictive epidemiology play more and more important roles in the prevention of cancers. Early biomarkers could identify the high risk population to have the possibilities of primary preventive interventions. It uses both molecular biological methods and the elements of epidemiology. Its specificity is not high enough to establish the diagnosis but it can be used to follow the "minimal residual disease" and with markers of individual susceptibility, to assesss the risk of tumors. As to the practice there are many problems because of the limited therapeutic possibilities, but the molecular and predictive epidemiology becomes an important part of medicine in the future.

AB - For many years the molecular biology has been one of the most promising fields of science and its several methods have been used in practice. These new methods of molecular biology made impression on epidemiology and developed a new disclipine, called molecular epidemiology. The molecular and predictive epidemiology play more and more important roles in the prevention of cancers. Early biomarkers could identify the high risk population to have the possibilities of primary preventive interventions. It uses both molecular biological methods and the elements of epidemiology. Its specificity is not high enough to establish the diagnosis but it can be used to follow the "minimal residual disease" and with markers of individual susceptibility, to assesss the risk of tumors. As to the practice there are many problems because of the limited therapeutic possibilities, but the molecular and predictive epidemiology becomes an important part of medicine in the future.

KW - Biomarker

KW - Molecular epidemiology

KW - Prevention

KW - Risk assessment

UR - http://www.scopus.com/inward/record.url?scp=2942568479&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=2942568479&partnerID=8YFLogxK

M3 - Article

C2 - 15085589

AN - SCOPUS:2942568479

VL - 145

SP - 507

EP - 514

JO - Orvosi Hetilap

JF - Orvosi Hetilap

SN - 0030-6002

IS - 10

ER -